Date: Thursday, February 17th, 2022

In this webinar, the CPS COVID Task Force reviewed insights and best practices pertaining to new developments in pharmacy related to the continuing COVID-19 pandemic.  Topics covered include virus variants, vaccine types, the therapeutic landscape, monoclonal antibodies, and more.

Topic: Updates and Insights from the COVID Task Force (22.02)

CPS provides resources, tools, and expertise to position pharmacies at our managed sites favorably to navigate the evolving circumstances of the COVID-19 pandemic.  During this webinar, the CPS COVID Task Force led a discussion reviewing insights and updates for hospitals and health systems seeking to "connect the dots" as they navigate their pharmacies through the pandemic.

Topics included:
• COVID-19 and variants
• Vaccines
• mAbs
• Antivirals (orals and changes to remdesivir)
• Logistic, legal, ethical, and billing/reimbursement considerations
• COVID Task Force value delivery at our manged sites

 
Presenters:

Chris Beebe

RPH, MBA

Compliance and Regulatory Services

Rabiah Dys

PharmD

Clinical Program Development

Chuck Fogle

PharmD

Clinical Solutions

Davey Legendre

PharmD, MBA, BCPS-AQID

Clinical Infectious Diseases

Valerie Sheehan

PharmD

Clinical Program Development

Renee Zawistowski

PharmD, BCCP

Quality and Operations